Non option equity instruments exercissable intrinsic value.

No definition available.

Name:	ZVSA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableIntrinsicValue
Namespace Prefix:	ZVSA_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Non option equity instruments exercisable number.

+ References

No definition available.

+ Details

Name:	ZVSA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
Namespace Prefix:	ZVSA_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Non option equity instruments exercisable weighted average exercise price.

+ References

No definition available.

+ Details

Name:	ZVSA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
Namespace Prefix:	ZVSA_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Non option equity instruments exercised weighted average exercise price.

+ References

No definition available.

+ Details

Name:	ZVSA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisedWeightedAverageExercisePrice
Namespace Prefix:	ZVSA_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Non option equity instruments issued weighted average exercise price.

+ References

No definition available.

+ Details

Name:	ZVSA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssuedWeightedAverageExercisePrice
Namespace Prefix:	ZVSA_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Non option equity instruments outstanding intrinsic value.

+ References

No definition available.

+ Details

Name:	ZVSA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingIntrinsicValue
Namespace Prefix:	ZVSA_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Non option equity instruments outstanding weighted average exercise price.

+ References

No definition available.

+ Details

Name:	ZVSA_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
Namespace Prefix:	ZVSA_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Non option equity instruments exercisable weighted average remaining contractual term.

+ References

No definition available.

+ Details

Name:	ZVSA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerm2
Namespace Prefix:	ZVSA_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Non option equity instruments outstanding weighted average remaining contractual term.

+ References

No definition available.

+ Details

Name:	ZVSA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2
Namespace Prefix:	ZVSA_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor".

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 27
-SubTopic 10
-Topic 852
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481435/852-10-45-27

+ Details

Name:	us-gaap_FinancialDesignationPredecessorAndSuccessorFixedList
Namespace Prefix:	us-gaap_
Data Type:	us-types:financialDesignationType
Balance Type:	na
Period Type:	duration

- Definition

Number of non-option equity instruments exercised by participants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Net number of non-option equity instruments granted to participants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(1)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of equity instruments other than options outstanding, including both vested and non-vested instruments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_FreshStartAdjustmentsTypeOfFreshStartAdjustmentAxis=ZVSA_PredecessorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Summary of Warrant Activity (Details) - USD ($)		1 Months Ended	3 Months Ended		11 Months Ended	12 Months Ended
Summary of Warrant Activity (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 12, 2022	Dec. 31, 2022	Dec. 31, 2021
Financial Designation, Predecessor and Successor [Fixed List]	Successor	Successor	Successor	Predecessor	Predecessor	Successor	Predecessor
Predecessor [Member]
Financial Designation, Predecessor and Successor [Fixed List]				Predecessor	Predecessor		Predecessor
Warrant [Member]
Number of warrants, outstanding, beginning balance		8,628,706	8,628,706
Weighted average exercise price, outstanding, beginning balance		$ 10.75	$ 10.75
Number of warrants, Issued
Weighted average exercise price, issued
Number of warrants, outstanding, ending balance	8,628,706	8,628,706			8,628,706	8,628,706
Weighted average exercise price, outstanding, ending balance	$ 10.75	$ 10.75			$ 10.75	$ 10.75
Weighted average remaining life, outstanding		4 years 9 months 18 days
Aggregate intrinsic value, outstanding, ending balance
Number of warrants, exercisable, ending balance	8,558,904	8,558,904				8,558,904
Weighted average exercise price, exercisable, ending balance	$ 10.79	$ 10.79				$ 10.79
Weighted average remaining life, exercisable		4 years 9 months 18 days
Aggregate intrinsic value, exercisable, ending balance
Warrant [Member] \| Predecessor [Member]
Number of warrants, outstanding, beginning balance		8,560,562		2,154,352	2,154,352	2,154,352
Weighted average exercise price, outstanding, beginning balance		$ 1.52		$ 1.98	$ 1.98	$ 1.98
Number of warrants, Issued					6,406,210
Weighted average exercise price, issued					$ 1.37
Number of warrants, outstanding, ending balance					8,560,562		2,154,352
Weighted average exercise price, outstanding, ending balance					$ 1.52		$ 1.98
Weighted average remaining life, outstanding					1 year 9 months 18 days
Aggregate intrinsic value, outstanding, ending balance					$ 59,681
Number of warrants, exercisable, ending balance					8,560,562
Weighted average exercise price, exercisable, ending balance					$ 1.55
Weighted average remaining life, exercisable					3 years 10 months 24 days
Aggregate intrinsic value, exercisable, ending balance					$ 34,203
Number of warrants, Exercised
Weighted average exercise price, exercised